Patents Assigned to FERA PHARMACEUTICALS, LLC
  • Method for treating vaso occlusive crises associated with sickle cell disease
    Patent number: 11660282
    Abstract: The present invention relates to a treatment of vaso-occlusive crisis (VOC) associated with Sickle cell disease by administering a therapeutically effective amount of 4-(nitrooxy)butyl-(2S)-2-(6-methoxy-2-naphthyl) propanoate.
    Type: Grant
    Filed: February 8, 2021
    Date of Patent: May 30, 2023
    Assignees: NICOX SA, FERA PHARMACEUTICALS, LLC
    Inventors: Brigitte Duquesroix-Chakroun, Frank J. Dellafera, Scott Florentino